Contribution of Linker Stability to the Activities of Anticancer ImmunoconjugatesStephen C. Alley, Peter D. Senter, Dennis R. Benjamin et al.|Bioconjugate Chemistry|2008Cited by 464
Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug ConjugateNicole M. Okeley, Stephen C. Alley, Russell J. Sanderson et al.|Clinical Cancer Research|2010Cited by 386
SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S.K. Sutherland, Julie A. McEarchern, Roland B. Walter et al.|Blood|2013Cited by 385
Development of orally active inhibitors of protein and cellular fucosylationNicole M. Okeley, Peter D. Senter, Stephen C. Alley et al.|Proceedings of the National Academy of Sciences|2013Cited by 189